These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 20427384)

  • 1. Molecular profiling in unknown primary cancer: accuracy of tissue of origin prediction.
    Greco FA; Spigel DR; Yardley DA; Erlander MG; Ma XJ; Hainsworth JD
    Oncologist; 2010; 15(5):500-6. PubMed ID: 20427384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A retrospective study of treatment outcomes in patients with carcinoma of unknown primary site and a colorectal cancer molecular profile.
    Hainsworth JD; Schnabel CA; Erlander MG; Haines DW; Greco FA
    Clin Colorectal Cancer; 2012 Jun; 11(2):112-8. PubMed ID: 22000811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular profiling of carcinoma of unknown primary and correlation with clinical evaluation.
    Varadhachary GR; Talantov D; Raber MN; Meng C; Hess KR; Jatkoe T; Lenzi R; Spigel DR; Wang Y; Greco FA; Abbruzzese JL; Hainsworth JD
    J Clin Oncol; 2008 Sep; 26(27):4442-8. PubMed ID: 18802157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular profiling diagnosis in unknown primary cancer: accuracy and ability to complement standard pathology.
    Greco FA; Lennington WJ; Spigel DR; Hainsworth JD
    J Natl Cancer Inst; 2013 Jun; 105(11):782-90. PubMed ID: 23641043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular gene expression profiling to predict the tissue of origin and direct site-specific therapy in patients with carcinoma of unknown primary site: a prospective trial of the Sarah Cannon research institute.
    Hainsworth JD; Rubin MS; Spigel DR; Boccia RV; Raby S; Quinn R; Greco FA
    J Clin Oncol; 2013 Jan; 31(2):217-23. PubMed ID: 23032625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective gene signature study using microRNA to identify the tissue of origin in patients with carcinoma of unknown primary.
    Varadhachary GR; Spector Y; Abbruzzese JL; Rosenwald S; Wang H; Aharonov R; Carlson HR; Cohen D; Karanth S; Macinskas J; Lenzi R; Chajut A; Edmonston TB; Raber MN
    Clin Cancer Res; 2011 Jun; 17(12):4063-70. PubMed ID: 21531815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular diagnosis of the tissue of origin in cancer of unknown primary site: useful in patient management.
    Greco FA
    Curr Treat Options Oncol; 2013 Dec; 14(4):634-42. PubMed ID: 23990214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA expression profiling with a droplet digital PCR assay enables molecular diagnosis and prognosis of cancers of unknown primary.
    Laprovitera N; Riefolo M; Porcellini E; Durante G; Garajova I; Vasuri F; Aigelsreiter A; Dandachi N; Benvenuto G; Agostinis F; Sabbioni S; Berindan Neagoe I; Romualdi C; Ardizzoni A; Trerè D; Pichler M; D'Errico A; Ferracin M
    Mol Oncol; 2021 Oct; 15(10):2732-2751. PubMed ID: 34075699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A quantitative reverse transcriptase-polymerase chain reaction assay to identify metastatic carcinoma tissue of origin.
    Talantov D; Baden J; Jatkoe T; Hahn K; Yu J; Rajpurohit Y; Jiang Y; Choi C; Ross JS; Atkins D; Wang Y; Mazumder A
    J Mol Diagn; 2006 Jul; 8(3):320-9. PubMed ID: 16825504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poorly differentiated neoplasms of unknown primary site: diagnostic usefulness of a molecular cancer classifier assay.
    Greco FA; Lennington WJ; Spigel DR; Hainsworth JD
    Mol Diagn Ther; 2015 Apr; 19(2):91-7. PubMed ID: 25758902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression profiling in patients with carcinoma of unknown primary site: from translational research to standard of care.
    Hainsworth JD; Greco FA
    Virchows Arch; 2014 Apr; 464(4):393-402. PubMed ID: 24487792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of types and primary sites of malignant tumors by examination of exfoliated tumor cells in serous fluids. Comparison with the diagnostic accuracy on small histologic biopsies.
    Spieler P; Gloor F
    Acta Cytol; 1985; 29(5):753-67. PubMed ID: 2996273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New strategies for carcinoma of unknown primary: the role of tissue-of-origin molecular profiling.
    Varadhachary G
    Clin Cancer Res; 2013 Aug; 19(15):4027-33. PubMed ID: 23519898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular classification of human cancers using a 92-gene real-time quantitative polymerase chain reaction assay.
    Ma XJ; Patel R; Wang X; Salunga R; Murage J; Desai R; Tuggle JT; Wang W; Chu S; Stecker K; Raja R; Robin H; Moore M; Baunoch D; Sgroi D; Erlander M
    Arch Pathol Lab Med; 2006 Apr; 130(4):465-73. PubMed ID: 16594740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Illumina whole-genome complementary DNA-mediated annealing, selection, extension and ligation platform: assessing its performance in formalin-fixed, paraffin-embedded samples and identifying invasion pattern-related genes in oral squamous cell carcinoma.
    Loudig O; Brandwein-Gensler M; Kim RS; Lin J; Isayeva T; Liu C; Segall JE; Kenny PA; Prystowsky MB
    Hum Pathol; 2011 Dec; 42(12):1911-22. PubMed ID: 21683979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accurate classification of metastatic brain tumors using a novel microRNA-based test.
    Mueller WC; Spector Y; Edmonston TB; St Cyr B; Jaeger D; Lass U; Aharonov R; Rosenwald S; Chajut A
    Oncologist; 2011; 16(2):165-74. PubMed ID: 21273512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular classification of cancers of unknown primary site.
    Greco FA; Erlander MG
    Mol Diagn Ther; 2009 Dec; 13(6):367-73. PubMed ID: 19925034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic role of a multigene reverse transcriptase-PCR assay in patients with node-negative breast cancer not receiving adjuvant systemic therapy.
    Esteva FJ; Sahin AA; Cristofanilli M; Coombes K; Lee SJ; Baker J; Cronin M; Walker M; Watson D; Shak S; Hortobagyi GN
    Clin Cancer Res; 2005 May; 11(9):3315-9. PubMed ID: 15867229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive Genomic Profiling of Carcinoma of Unknown Primary Site: New Routes to Targeted Therapies.
    Ross JS; Wang K; Gay L; Otto GA; White E; Iwanik K; Palmer G; Yelensky R; Lipson DM; Chmielecki J; Erlich RL; Rankin AN; Ali SM; Elvin JA; Morosini D; Miller VA; Stephens PJ
    JAMA Oncol; 2015 Apr; 1(1):40-49. PubMed ID: 26182302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Robustness of biomarker determination in breast cancer by RT-qPCR: impact of tumor cell content, DCIS and non-neoplastic breast tissue.
    Hartmann K; Schlombs K; Laible M; Gürtler C; Schmidt M; Sahin U; Lehr HA
    Diagn Pathol; 2018 Oct; 13(1):83. PubMed ID: 30342538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.